← Browse by Condition
Medical Condition

obsessive compulsive disorder

Total Trials
14
Recruiting Now
14
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for obsessive compulsive disorder sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — obsessive compulsive disorder Clinical Trials

How many clinical trials are currently recruiting for obsessive compulsive disorder?
ClinicalMetric currently tracks 14 actively recruiting clinical trials for obsessive compulsive disorder, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for obsessive compulsive disorder?
obsessive compulsive disorder research spans Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a obsessive compulsive disorder clinical trial?
Eligibility criteria for obsessive compulsive disorder trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
2
Top Sponsors
Shanghai Mental Health Center 2 trials
National Institute of Mental Health (NIMH) 1 trial
University of Wisconsin, Milwaukee 1 trial
Mclean Hospital 1 trial
Vanderbilt University Medical Center 1 trial

Recruiting Clinical Trials

NCT04631042
Recruiting
Developing Brain, Impulsivity and Compulsivity
Enrollment
1,100 pts
Location
United States
Sponsor
National Institute of Mental H...
View Trial →
NCT04539951 Phase 2
Recruiting
Pragmatic Trial of Obsessive-compulsive Disorder
Enrollment
1,600 pts
Location
China
Sponsor
Shanghai Mental Health Center
View Trial →
NCT05377125
Recruiting
Neural Mechanisms of Response Inhibition Training for OCRD
Enrollment
118 pts
Location
United States
Sponsor
University of Wisconsin, Milwa...
View Trial →
NCT05224414
Recruiting
Interpretation Bias as a Mechanism of Treatment Response in OCD
Enrollment
106 pts
Location
United States
Sponsor
Mclean Hospital
View Trial →
NCT00575081
Recruiting
Physiological Brain Atlas Development
Enrollment
5,000 pts
Location
United States
Sponsor
Vanderbilt University Medical ...
View Trial →
NCT07728994 Phase 2
Recruiting
SONATA LIFU for OCD
Enrollment
40 pts
Location
United States
Sponsor
University of Pennsylvania
View Trial →
NCT06017713
Recruiting
tDCS Associated With Symptom Provocation in the Management of Patients With Resistant Obsessive Compulsive Disorder
Enrollment
25 pts
Location
France
Sponsor
Centre Hospitalier Henri Labor...
View Trial →
NCT06660225
Recruiting
Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder
Enrollment
10 pts
Location
United States
Sponsor
Nader Pouratian
View Trial →
NCT03953014
Recruiting
Pharmacogenetics of Antidepressant-Induced Disinhibition
Enrollment
120 pts
Location
Canada
Sponsor
University of Calgary
View Trial →
NCT07198594
Recruiting
Accelerated rTMS Therapeutic Approach for Refractory Obsessive-Compulsive Disorder
Enrollment
20 pts
Location
China
Sponsor
Shanghai Pudong New Area Menta...
View Trial →
NCT06262464
Recruiting
An OCD Prevention Programme for at Risk Adults
Enrollment
200 pts
Location
Romania
Sponsor
Babes-Bolyai University
View Trial →
NCT07704632
Recruiting
Safety and Feasibility of FUS Next Generation Dome Helmet (NGDH) to Perform Neuromodulation in Patients With Treatment Refractory Obsessive Compulsive Disorder (OCD)
Enrollment
20 pts
Location
Canada
Sponsor
Sunnybrook Health Sciences Cen...
View Trial →
NCT07834567
Recruiting
Clinical and Biological Correlates of Obsessive-Compulsive Disorder and Online Mindfulness-Based Cognitive Therapy
Enrollment
42 pts
Location
Italy
Sponsor
IRCCS Centro San Giovanni di D...
View Trial →
NCT07031544
Recruiting
Efficacy and Influencing Factors of ALIC-NAc Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive Disorder
Enrollment
60 pts
Location
China
Sponsor
Shanghai Mental Health Center
View Trial →

Related Conditions

obsessive compulsive disorder ocd (2) typical development (1) conduct disorder (1) attention deficit hyperactivity disorder (1) autism spectrum disorder (1) tricholemmoma (1) skin picking (1) parkinson s disease (1) dystonia (1) essential tremor (1) epilepsy (1) anxiety disorders (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology